tiprankstipranks
Baudax Bio (BXRX)
OTHER OTC:BXRX
US Market

Baudax Bio (BXRX) Cash flow

760 Followers

Baudax Bio Cash Flow

BXRX's free cash flow for Q2 2023 was $-3.64M. For the 2023 fiscal year, BXRX's free cash flow was decreased by $-14.76M and operating cash flow was $-3.64M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -15.97M$ -27.79M$ -12.85M$ -44.06M$ -50.04M$ -59.75M
Investing Cash Flow
$ 333.00K$ -20.00K$ -33.51M$ -639.00K$ -1.48M$ -3.45M
Financing Cash Flow
$ 11.85M$ 17.18M$ 35.01M$ 57.30M$ 69.27M$ 63.20M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 16.13M$ 5.26M$ 19.00M$ 30.34M$ 17.74M$ 0.00
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
$ 13.15M$ 18.64M-$ 45.01M$ 0.00-
Issuance Of Debt
$ -4.63M$ -2.24M-$ 10.04M$ 0.00-
Repayment Of Debt
$ -5.47M$ -2.24M----
Free Cash Flow
$ -15.97M$ -27.81M$ -13.05M$ -44.70M$ -51.53M$ -63.20M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Baudax Bio Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis